GenVec, Inc. (NASDAQ:GNVC)
| CAPS Rating |
|
|---|
GNVC
VS S&P 500 (SPY)
GNVC News and Commentary
- Life Sciences Companies Raise Record Amounts of Capital – SeekingAlpha
- GenVec, Merial Team up to Develop Food-and-Mouth Disease Vaccine – Fox Business
- Amgen, Celgene and Novartis in the Fight Against Pancreatic Cancer – SeekingAlpha
- Competitive Technologies: Short Squeeze Coming or Another Leg Down? – SeekingAlpha
- Stocks Claw Back to End Day Lower, Week Higher – SeekingAlpha
- 3 Stocks to Play Biotech – The Motley Fool
- UPDATE 1-GenVec shrs plunge after cancer drug trial discontinued – Reuters
- GenVec Halts Phase III Trial Of TNFerade For Pancreatic Cancer – SmartMoney
- UPDATE 1-GenVec says cancer drug not effective, ends trial – Reuters
This ticker is not currently Ratable.
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPSAll Players
277
Outperform
12
Underperform
All-Star Players
43
Outperform
3
Underperform
Wall Street
1
Outperform
0
Underperform
RSS Headlines
Fool UK
